In searching for potential new targets for the development of effective drugs against MASLD, we found that glutathione S-transferase alpha 1 (GSTA1) may be related to the accumulation of lipid droplets (LD). Here, GSTA1 is linked to metabolic dysfunction-associated steatotic liver disease.